domingo, 23 de junio de 2019

The changing narrative of MRSA infection control in the United States - On Health

The changing narrative of MRSA infection control in the United States - On Health

Dr. Kevin Kavanagh

Dr. Kevin Kavanagh

Kevin Kavanagh, MD, MS is Board Chairman of Health Watch USA, a non-profit patient safety healthcare policy organization. He is an Associate Editor of the Journal of Patient Safety and serves on the National Quality Forum’s Consensus Standards Approval Committee (CSAC) and the Centers for Medicaid and Medicare Services’ Hospital-Acquired Condition (HAC) Reduction Program Technical Expert Panel (TEP).


The changing narrative of MRSA infection control in the United States

MRSA is now endemic in the United States with approximately 2% of the general population carrying the disease. In a commentary published today in Antimicrobial Resistance & Infection Control, Dr. Kevin Kavanagh talks us through the events that led to this situation and makes the case for combatting the issue through universal screening of MRSA on admission to U.S. hospitals.
A quote often attributed to Winston Churchill aptly observed “The Americans can always be trusted to do the right thing, once all other possibilities have been exhausted.” This observation has never been truer when one looks at our approach to the control of MRSA. Through a series of policy iterations, the United States appears to have progressed from MRSA being a serious public health problem which has to be controlled, to one which we do not have control and usually it “is no big deal”.

No hay comentarios:

Publicar un comentario